Ventum Cap Mkts upgraded shares of Cresco Labs (OTCMKTS:CRLBF – Free Report) to a strong-buy rating in a research note published on Friday morning, Zacks.com reports. Ventum Cap Mkts also issued estimates for Cresco Labs’ Q3 2024 earnings at ($0.01) EPS, Q4 2024 earnings at ($0.01) EPS, FY2024 earnings at ($0.16) EPS and FY2025 earnings at ($0.03) EPS.
CRLBF has been the subject of a number of other reports. Wedbush upped their price target on shares of Cresco Labs from $2.50 to $3.00 and gave the company an outperform rating in a report on Thursday, May 16th. Roth Capital raised shares of Cresco Labs from a hold rating to a strong-buy rating in a research report on Friday. Finally, Needham & Company LLC reaffirmed a hold rating on shares of Cresco Labs in a research report on Thursday, May 16th. Two equities research analysts have rated the stock with a hold rating, three have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of Buy and a consensus target price of $2.63.
Check Out Our Latest Research Report on Cresco Labs
Cresco Labs Trading Down 4.0 %
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.15). The company had revenue of $184.36 million for the quarter, compared to analysts’ expectations of $184.26 million. Cresco Labs had a negative net margin of 20.32% and a negative return on equity of 6.78%. Research analysts predict that Cresco Labs will post -0.03 EPS for the current year.
Cresco Labs Company Profile
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Featured Articles
- Five stocks we like better than Cresco Labs
- Investing In Automotive Stocks
- MarketBeat Week in Review – 8/5 – 8/9
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- Find and Profitably Trade Stocks at 52-Week Lows
- The Cannabis Sector: Profitability Takes Center Stage
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.